Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandrasekhar Bal

Showing results (81-90 of 328) with videos related to

Pageof 33
Sort By:
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|September 12, 2014
Metastatic superscan on (99m)Tc-MDP bone scintigraphy in a case of carcinoma colon: Common finding but rare etiologyPartha Sarathi Chakraborty, Punit Sharma, Sellam Karunanithi, et al.
Clinical Nuclear Medicine|November 13, 2013
Lymphoma as a second malignancy in a patient with neuroendocrine tumor: mimicking dedifferentiation on dual-tracer PET/CT with 68Ga-DOTANOC and 18F-FDGSachin Jain, Punit Sharma, Varun Singh Dhull, et al.
Indian Journal of Endocrinology and Metabolism|July 28, 2012
Incidental detection of hyperfunctioning thyroid cancer metastases in patients presenting with thyrotoxicosisNishikant A Damle, Chandrasekhar Bal, Praveen Kumar, et al.
Nuclear Medicine Communications|August 16, 2020
RET gene mutation analysis and long-term clinical outcomes of medullary thyroid cancer patientsMeghana Prabhu, Sunil Shakya, Sanjana Ballal, et al.
Nuclear Medicine Communications|April 16, 2016
Study of cytogenetic toxicity of low-dose radioiodine therapy in hyperthyroid patients using a micronuclei assayGirish K Parida, Chandrasekhar Bal, Rima Dada, et al.
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|May 2, 2019
<sup>18</sup>F-Fludeoxyglucose Positron-emission Tomography/Computed Tomography in Encephalocraniocutaneous Lipomatosis/Haberland SyndromeSarthak Tripathy, Madhavi Tripathi, Manjari Tripathi, et al.
Clinical Nuclear Medicine|February 24, 2015
Radiation-Induced Esophagitis Masquerading as Disease Progression in Case of Esophageal Carcinoma: A Diagnostic Dilemma Solved on Follow-up FDG PET/CTAnirban Mukherjee, Partha Sarathi Chakraborty, Abhishek Behera, et al.
Clinical Nuclear Medicine|October 3, 2014
Erlotinib-induced cutaneous toxicity: findings on 18F-FDG PET/CT imagingKunal Kumar, Harmandeep Singh, Ravi Kant Gupta, et al.
Clinical Nuclear Medicine|November 13, 2013
Peptide receptor radionuclide therapy with (177)Lu DOTATATE in a case of recurrent carotid body paraganglioma with spinal metastasesSantosh Kumar Gupta, Suhas Singla, Sellam Karunanithi, et al.
EJNMMI Research|October 28, 2020
[<sup>177</sup>Lu]Lu-DOTA-ZOL bone pain palliation in patients with skeletal metastases from various cancers: efficacy and safety resultsMadhav Prasad Yadav, Sanjana Ballal, Marian Meckel, et al.
Pageof 33

Showing results (81-90 of 328) with videos related to

Sort By:
Pageof 33
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|September 12, 2014
Metastatic superscan on (99m)Tc-MDP bone scintigraphy in a case of carcinoma colon: Common finding but rare etiologyPartha Sarathi Chakraborty, Punit Sharma, Sellam Karunanithi, et al.
Clinical Nuclear Medicine|November 13, 2013
Lymphoma as a second malignancy in a patient with neuroendocrine tumor: mimicking dedifferentiation on dual-tracer PET/CT with 68Ga-DOTANOC and 18F-FDGSachin Jain, Punit Sharma, Varun Singh Dhull, et al.
Indian Journal of Endocrinology and Metabolism|July 28, 2012
Incidental detection of hyperfunctioning thyroid cancer metastases in patients presenting with thyrotoxicosisNishikant A Damle, Chandrasekhar Bal, Praveen Kumar, et al.
Nuclear Medicine Communications|August 16, 2020
RET gene mutation analysis and long-term clinical outcomes of medullary thyroid cancer patientsMeghana Prabhu, Sunil Shakya, Sanjana Ballal, et al.
Nuclear Medicine Communications|April 16, 2016
Study of cytogenetic toxicity of low-dose radioiodine therapy in hyperthyroid patients using a micronuclei assayGirish K Parida, Chandrasekhar Bal, Rima Dada, et al.
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|May 2, 2019
<sup>18</sup>F-Fludeoxyglucose Positron-emission Tomography/Computed Tomography in Encephalocraniocutaneous Lipomatosis/Haberland SyndromeSarthak Tripathy, Madhavi Tripathi, Manjari Tripathi, et al.
Clinical Nuclear Medicine|February 24, 2015
Radiation-Induced Esophagitis Masquerading as Disease Progression in Case of Esophageal Carcinoma: A Diagnostic Dilemma Solved on Follow-up FDG PET/CTAnirban Mukherjee, Partha Sarathi Chakraborty, Abhishek Behera, et al.
Clinical Nuclear Medicine|October 3, 2014
Erlotinib-induced cutaneous toxicity: findings on 18F-FDG PET/CT imagingKunal Kumar, Harmandeep Singh, Ravi Kant Gupta, et al.
Clinical Nuclear Medicine|November 13, 2013
Peptide receptor radionuclide therapy with (177)Lu DOTATATE in a case of recurrent carotid body paraganglioma with spinal metastasesSantosh Kumar Gupta, Suhas Singla, Sellam Karunanithi, et al.
EJNMMI Research|October 28, 2020
[<sup>177</sup>Lu]Lu-DOTA-ZOL bone pain palliation in patients with skeletal metastases from various cancers: efficacy and safety resultsMadhav Prasad Yadav, Sanjana Ballal, Marian Meckel, et al.
Pageof 33